Search

everythinglearnresearchcommunity

for

Search:↓

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Pregnancy can trigger follicular mucinosis, which may resolve after delivery.

Chemical exposure may contribute to the rise in atopic diseases and needs more research.

Cholecystokinin may help reduce skin inflammation in psoriasis.

A new one-step test can quickly identify skin cancer during surgery.

Topical glucocorticoids thin the skin and change collagen structure.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Deep phenotyping helps distinguish between xeroderma pigmentosum and trichothiodystrophy, aiding in diagnosis and treatment.

Higher leptin levels link to hair loss.

Alopecia areata is a hair loss disease caused by complex immune reactions, and new targeted treatments show promise.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Probiotic bacteria improved skin and hair health in aged mice.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

Biologics show promise in treating various stubborn skin diseases, but more research and better reimbursement criteria are needed.

Topical treatments led to hair regrowth in a man with linear morphea.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Regulatory T cells are essential for normal and improved wound healing in mice.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Targeting IL-17 could help treat pattern hair loss.

IL6 is linked to higher risk of heart disease in people with a certain mouth condition.

A man's gray hair got darker and thicker after using a psoriasis drug.